GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » FCF Yield %

Vectus Biosystems (ASX:VBS) FCF Yield %

: -10.60 (As of Today)
View and export this data going back to 2016. Start your Free Trial

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Vectus Biosystems's Trailing 12-Month Free Cash Flow is A$-1.38 Mil, and Market Cap is A$13.57 Mil. Therefore, Vectus Biosystems's FCF Yield % for today is -10.60%.

The historical rank and industry rank for Vectus Biosystems's FCF Yield % or its related term are showing as below:

ASX:VBS' s FCF Yield % Range Over the Past 10 Years
Min: -17.83   Med: 0   Max: 0
Current: -10.6


ASX:VBS's FCF Yield % is ranked better than
57.23% of 1550 companies
in the Biotechnology industry
Industry Median: -14.565 vs ASX:VBS: -10.60

Vectus Biosystems's FCF Margin % for the quarter that ended in Dec. 2023 was -86,200.00%.


Vectus Biosystems FCF Yield % Historical Data

The historical data trend for Vectus Biosystems's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
FCF Yield %
Premium Member Only Premium Member Only Premium Member Only -13.10 -17.63 -7.62 -12.49 -10.13

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.70 -12.53 -9.53 -4.44 -10.80

Competitive Comparison

For the Biotechnology subindustry, Vectus Biosystems's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems FCF Yield % Distribution

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's FCF Yield % falls into.



Vectus Biosystems FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Vectus Biosystems's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.37 / 23.40338
=-10.13%

Vectus Biosystems's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.862 * 2 / 15.96282
=-10.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Vectus Biosystems FCF Yield % Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems (ASX:VBS) Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines